Michael R. Tranfaglia

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Qijiang Yan, Mustapha Rammal, Michael R. Tranfaglia et al. · Neuropharmacology · 2005 · 521 citations

Knockout Mouse, Molecular Pharmacology, Molecular Neuroscience +8

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

Elizabeth Berry‐Kravis, David Hessl, Sarah M. Coffey et al. · Journal of Medical Genetics · 2009 · 410 citations · Full text

Open-label add-on treatment trial of minocycline in fragile X syndrome

Carlo Paribello, Leeping Tao, Anthony Folino et al. · BMC Neurology · 2010 · 217 citations · Full text

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice

Cara J. Westmark, Pamela R. Westmark, Kenneth J. O’Riordan et al. · PLoS ONE · 2011 · 111 citations · Full text

Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Catherine H. Choi, Brian P. Schoenfeld, Aaron Bell et al. · Brain Research · 2010 · 106 citations · Full text

Synaptic Plasticity, Synaptic Plasticity Deficits, Neurophysiology +12